Smoldering multiple myeloma: present position and potential promises.

about

Smoldering multiple myeloma European perspective on multiple myeloma treatment strategies in 2014

P2860

Q26863331-0EED4CDA-31F8-4C7B-9D0B-01498344D1D9 Q27005966-FA0F8DBF-FA56-49BE-BDFC-43ACA3AE06BF

P2860

Smoldering multiple myeloma: present position and potential promises.

Item

http://www.wikidata.org/entity/Q38151230

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Smoldering multiple myeloma: present position and potential promises.

@en

type

Item

label

Smoldering multiple myeloma: present position and potential promises.

@en

prefLabel

Smoldering multiple myeloma: present position and potential promises.

@en

P1476

Smoldering multiple myeloma: present position and potential promises.

@en

P2093

Elisabet E Manasanch

http://www.w3.org/2001/XMLSchema#string

Manisha Bhutani

http://www.w3.org/2001/XMLSchema#string

Mark Roschewski

http://www.w3.org/2001/XMLSchema#string

Mary Kwok

http://www.w3.org/2001/XMLSchema#string

Neha Korde

http://www.w3.org/2001/XMLSchema#string

Nishant Tageja

http://www.w3.org/2001/XMLSchema#string

Sham Mailankody

http://www.w3.org/2001/XMLSchema#string

P2860

Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

Seven-year median time to progression with thalidomide for smoldering myeloma: partial response identifies subset requiring earlier salvage therapy for symptomatic disease

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis

Prevention of progression in monoclonal gammopathy of undetermined significance

Clinical and biological significance of RAS mutations in multiple myeloma.

MicroRNAs: genomics, biogenesis, mechanism, and function

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma

International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma

P304

1-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/EJH.12205

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ola Landgren

P577

2013-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257646099

http://www.w3.org/2001/XMLSchema#string

P698

24112232

http://www.w3.org/2001/XMLSchema#string

Smoldering multiple myeloma: present position and potential promises.

about

P2860

P2860

Smoldering multiple myeloma: present position and potential promises.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698